The workshop ‘Optimising the innovation environment to tackle healthcare challenges through a synergistic application of HTA and PPI’ will discuss how Health Technology Assessment (HTA) and Public Procurement of Innovation (PPI) can enable the rapid development and uptake of solutions to address unmet healthcare organisations needs and improve the quality and efficiency of healthcare services.
Innovation is an important driver of progress, and nowhere is this more evident than in the healthcare sector. From novel treatments to cutting-edge technologies, innovative solutions have the potential to transform healthcare and improve patient outcomes. However, innovation alone is not enough. To fully realise the potential of these new solutions, we need to create an environment that encourages innovation and supports the adoption and scaling of new technologies and approaches.
Public Procurement of Innovation (PPI) is a procurement process that can help healthcare organisations stimulate innovation and address unmet needs. By using PPI, healthcare providers can identify and acquire innovative solutions that improve the quality and efficiency of healthcare services. PPI can also support the growth of the healthcare sector by creating positive market conditions for innovation.
Health Technology Assessment (HTA) is another important tool that can be used to support innovation in healthcare. HTA is a systematic and multidisciplinary process that evaluates the safety, effectiveness, and cost-effectiveness of new technologies. By providing an evidence-based assessment of the value of new solutions, HTA can help healthcare providers make informed decisions about which solutions to adopt. Together, PPI and HTA can create positive market conditions for innovation and support the growth of the healthcare sector.
Do not miss this discussion with PPI, HTA and market access experts as well as policymakers where you will explore the scope for synergy and mutual benefit of HTA and PPI in driving innovation and improving the efficiency, quality, and sustainability of healthcare.
This session will feature Ms Rossana Alessandrello, Value Based Procurement Director at AQuAS – Salut; Ms Sofia Moreno-Pérez, Innovation & business development, Active and Healthy Aging at VALDE Consulting; Dr Laura Sampietro-Colom, MD, Deputy Director of Innovation and Head of the Health Technology Assessment Unit at the Hospital Clinic of Barcelona; and Mr Yves Verboven, Founder of EU4HealthSolutions. Mr George Valiotis, Executive Director at the European Health Management Association, will facilitate the discussion.
We encourage you to check out the #EHMA2023 programme here and discover the over 50 sessions we have this year. Register before Friday, 26 May here to secure your spot at this significant conversation.
This session is offered to you by the EcoQUIP+ project.
